ReviewFrontiers in genetics2026
The multifaceted roles of microRNAs in nonalcoholic steatohepatitis: from pathogenic mechanisms to diagnostic and therapeutic opportunities.
Review in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonalcoholic steatohepatitis (NASH), a significant advanced stage of nonalcoholic fatty liver disease (NAFLD), has become a focal point in contemporary liver disease research due to its intricate pathological characteristics and high prevalence. MicroRNAs (miRNAs), as pivotal regulators of gene expression, play pivotal roles in the pathophysiology of lipid metabolism disorders, inflammatory responses, apoptosis, and liver fibrosis during NASH progression. Despite recent preliminary insights into the functional roles of miRNAs in NASH, their specific mechanisms and clinical applications remain challenging. This systematic Frontiers in Immunology review examines miRNA expression patterns and the signaling pathways that regulate them, focusing on the diagnostic potential of circulating and exosomal miRNAs in NASH and the latest advances in miRNA-based therapeutic strategies. The objective of the present study is to integrate multi-omics and clinical research data to provide theoretical support and practical guidance for early diagnosis and precision treatment of NASH. The ultimate aim is to advance the translational application of microRNAs in clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.